Servicios Personalizados
Revista
Articulo
Indicadores
Citado por SciELO
Accesos
Links relacionados
Citado por Google
Similares en SciELO
Similares en Google
Compartir
Revista de la Facultad de Medicina
versión impresa ISSN 0120-0011
Resumen
RINCON, Erika Andrea; GOMEZ, Juan Esteban y PACHAJOA, Harry Mauricio. Clinical and molecular characterization in homozygous familial hypercholesterolemia. rev.fac.med. [online]. 2018, vol.66, n.3, pp.505-508. ISSN 0120-0011. https://doi.org/10.15446/revfacmed.v66n3.63503.
Introduction:
Homozygous familial hypercholesterolemia is a rare genetic disorder characterized by very high cholesterol levels and poor response to conventional pharmacological treatment (statins, ezetimibe). Molecular study is an important resource that may have a positive impact on the treatment and prognosis of these patients; however, this type of study is not always available in all care centers. The results of these genetic tests allow identifying patients who can benefit from new therapeutic options associated with a higher decrease of total and LDL cholesterol.
Case presentation:
This paper presents the cases of two sisters with severe hypercholesterolemia and poor response to conventional pharmacological treatment, in whom molecular diagnosis confirmed a homozygosis mutation in the low density lipoprotein receptor gene. Based on these results, in both cases, a selective microsomal triglyceride transfer protein inhibitor was added to conventional lipid-lowering therapy, which resulted in a decrease of serum levels in total and LDL cholesterol by more than 49%.
Conclusion:
Molecular tests are an important tool to define the diagnosis, prognosis and treatment of patients with homozygous familial hypercholesterolemia.
Palabras clave : Hypercholesterolemia; Cholesterol; Mutation (MeSH).